Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Mark Emberton

201-229 of 229 results

Data of a stiffness softening mechanism effect on proliferation and differentiation of a human bone marrow derived mesenchymal stem cell line towards the chondrogenic and osteogenic lineages

A randomized controlled trial to investigate magnetic resonance imaging-targeted biopsy as an alternative diagnostic strategy to transrectal ultrasound-guided prostate biopsy in the diagnosis of prostate cancer

scientific article published on 5 January 2015

Genetic correlates of prostate cancer visibility (and invisibility) on multiparametric magnetic resonance imaging: it's time to take stock

scientific article published on 20 December 2019

Protocol for a MULTI-centre feasibility study to assess the use of99mTc-sestaMIBI SPECT/CT in the diagnosis of kidney tumours (MULTI-MIBI study)

scholarly article

MP70-02 CORRELATION OF MPMRI CONTOURS WITH 3-DIMENSIONAL 5MM TRANSPERINEAL PROSTATE MAPPING BIOPSY WITHIN THE PROMIS TRIAL PILOT: WHAT MARGINS ARE REQUIRED?

Are we ready for the new wave of focal therapy interventions for men with early prostate cancer?

scientific article published on August 1, 2013

Prostate cancer treated with irreversible electroporation: MRI-based volumetric analysis and oncological outcome

scientific article published on 12 February 2019

Exploring Patient Views and Acceptance of Multiparametric Magnetic Resonance Imaging for the Investigation of Suspected Prostate Cancer (the PACT Study): A Mixed-Methods Study Protocol

scientific article published on 28 March 2020

The University College London/Medical Research Council/National Institute of Health Research-Health Technology Assessment PROMIS Trial: An Update

scientific article published on September 1, 2015

Translating cost-utility modelling into the real world - the case of focal high-intensity focussed ultrasound and active surveillance

scientific article published on 01 December 2019

Defining an Ageing-Related Pathology, Disease or Syndrome: International Consensus Statement

Editorial comment: Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes

scientific article published on 29 August 2012

Spectrum of metastatic and nonmetastatic skeletal findings with dual-phase 18F-FECH PET/CT in patients with biochemical relapse of prostate cancer

scientific article published on 4 April 2017

Volume-mortality for cystectomy. Centralisation of cancer services vindicated

scientific article published on 22 June 2010

Has tailored, tissue-selective tumour ablation in men with prostate cancer come of age?

scientific article published on 01 May 2018

Re: Salvage Radical Prostatectomy Following Primary High Intensity Focused Ultrasound for Treatment of Prostate Cancer

scientific article published on July 23, 2011

Dropping the GAD - just a fad? The case for a simpler, quicker, safer and cheaper prostate magnetic resonance imaging

scientific article published on 01 August 2019

Conspicuity of cribriform prostate cancer on multiparametric magnetic resonance imaging: the jury is still out

scientific article published on 13 November 2020

MP38-07 SHOULD WE AIM FOR THE CENTRE OF AN MRI PROSTATE LESION? CORRELATION BETWEEN MPMRI AND 3-DIMENSIONAL 5MM TRANSPERINEAL PROSTATE MAPPING BIOPSIES FROM THE PROMIS TRIAL

Re: A Critical Analysis of the Tumor Volume Threshold for Clinically Insignificant Prostate Cancer Using a Data Set of a Randomized Screening Trial

scientific article published on July 23, 2011

Prostate Cancer Visibility on Multiparametric Magnetic Resonance Imaging: High Gleason Grade and Increased Tumour Volume are Not the Only Important Histopathological Features

scientific article published on 22 April 2020

Prolonging survival in prostate cancer: chemotherapy will have an important role

scientific article published in July 2005

MP70-18 PROSTATE RADIOFREQUENCY ABLATION FOCAL TREATMENT (PRORAFT): INTERIM RESULTS OF A PROSPECTIVE DEVELOPMENT STUDY

MP30-05 PROSTATE RADIOFREQUENCY ABLATION FOCAL TREATMENT (PRORAFT): RESULTS OF A PROSPECTIVE DEVELOPMENT STUDY FOR LOCALISED PROSTATE CANCER

MP77-20 PREDICTION OF SIGNIFICANT PROSTATE CANCER IN BIOPSY-NAÏVE MEN: EXTERNAL VALIDATION OF A NOVEL RISK MODEL COMBINING MRI AND CLINICAL PARAMETERS

Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol

Re: Jochen Walz. The "PROMIS" of Magnetic Resonance Imaging Cost Effectiveness in Prostate Cancer Diagnosis? Eur Urol 2018;73:31-2.

scientific article published on 17 February 2018

Hormone therapy: a revolution in understanding prostate cancer

scientific article published in November 2008

Life after prostate cancer. Time to evaluate focal therapy

scientific article